Comparison of cycloplegia at 20- and 30-minutes following proxymetacaine and cyclopentolate instillation in white 12-13-year-olds

Doyle, Meagan; O’Dwyer, Veronica; Harrington, Síofra

doi:10.1080/08164622.2023.2166398

Cited by 1 publication

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cyclopentolate cycloplegia was achieved with one drop of 1% cyclopentolate hydrochloride (one drop of cyclopentolate group; Bausch and Lomb Minims; http://bausch.fr; with the average time for onset of cycloplegia being 20 min 22 ) in both eyes after topical anaesthesia with 0.5% proxymetacaine hydrochloride (Bausch and Lomb Minims, http://bausch.fr). An additional drop of 1% cyclopentolate hydrochloride was instilled in participants (two drops of cyclopentolate group) with brown or dark brown irides 5 min after the first drop, in accordance with the study protocol.…”

Section: Methodsmentioning

confidence: 99%

Short‐term effects of cyclopentolate and tropicamide eye drops on macular choroidal thickness in myopic children

Kobia‐Acquah,

Flitcroft,

Lingham

et al. 2023

Ophthalmic Physiologic Optic

View full text Add to dashboard Cite

BackgroundTo investigate the short‐term effects of cyclopentolate and tropicamide eyedrops on choroidal thickness (ChT) in myopic children using placebo or low‐dose atropine eyedrops.MethodsThe analysis included 242 myopic individuals (7–19 years) enrolled in two randomised placebo‐controlled clinical trials of low‐dose atropine eyedrops. Cycloplegia was induced using either one drop of 1% cyclopentolate (n = 161), two drops of 1% cyclopentolate (n = 32) or two drops of 1% tropicamide (n = 49). ChT measurements were taken using swept‐source optical coherence tomography before and 30 min after administering the cycloplegic eye drops. A subset of 51 participants underwent test–retest measurements prior to cycloplegia.ResultsMean changes in subfoveal ChT after two drops of tropicamide and one and two drops of cyclopentolate were −2.5 μm (p = 0.10), −4.3 μm (p < 0.001) and −9.6 μm (p < 0.001), respectively. Subfoveal ChT changes after one and two drops of cyclopentolate were significantly greater than the test–retest changes (test–retest mean change: −3.1 μm; p < 0.05), while the tropicamide group was not significantly different (p = 0.64). Choroidal thinning post‐cyclopentolate was not significantly different between atropine and placebo treatment groups (p > 0.05 for all macular locations). The coefficient of repeatability (CoR) in the tropicamide group (range: 8.2–14.4 μm) was similar to test–retest (range: 7.5–12.2 μm), whereas greater CoR values were observed in the cyclopentolate groups (one drop: range: 10.8–15.3 μm; two drops: range: 12.2–24.6 μm).ConclusionsCyclopentolate eye drops caused dose‐dependent choroidal thinning and increased variation in pre‐ to post‐cycloplegia measurements compared with test–retest variability, whereas tropicamide did not. These findings have practical implications for ChT measurements when cyclopentolate is used, particularly for successive measurements.

show abstract

Section: Methodsmentioning

confidence: 99%